Abnormal electrophysiological testing associates with future incidental significant arrhythmia in scleroderma.
暂无分享,去创建一个
S. Plein | J. Greenwood | A. Burska | L. Graham | M. Buch | J. Biglands | G. Abignano | G. Fent | H. Donica | A. Kidambi | F. Galdo | R. Dumitru | B. Erhayiem | L. Bissell
[1] S. Plein,et al. Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP , 2019, Rheumatology.
[2] A. Larsson,et al. Electrocardiography in 110 patients with systemic sclerosis: a cross-sectional comparison with population-based controls , 2014, Scandinavian journal of rheumatology.
[3] E. Feierl,et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database , 2010, Annals of the rheumatic diseases.
[4] S. Calvieri,et al. Noninvasive assessment of myocardial involvement in patients with systemic sclerosis: role of signal averaged electrocardiography. , 1997, The Journal of rheumatology.
[5] A. Masi,et al. Prognostic importance of cardiac arrhythmias in systemic sclerosis. , 1988, The American journal of medicine.